top of page
About
Dr Howard L. McLeod, FASCO, FCCP
DIRECTOR, CENTER FOR PRECISION MEDICINE & FUNCTIONAL GENOMICS
PROFESSOR OF PHARMACY AND MEDICINE
EDUCATION
1988 - B.S. - University of Washington School of Pharmacy
1990 - Pharm.D. - Philadelphia College of Pharmacy and Science
Post-Doctoral Training
July 1990 - December 1992 Clinical Research Fellow (Mentor: Prof William E Evans), St Jude
Children’s Research Hospital, Memphis, TN, USA.
January-December 1993 - Research Fellow (Mentor: Prof Paul Workman), CRC Dept. of
Medical Oncology, Cancer Research Campaign Beatson Laboratories, University of Glasgow, Glasgow, UK.
March/April, 2020 - Prescription Drug Regulation, Cost, and Access: Current Controversies in Context. 1962USRx Harvard University, Boston, USA.
Education
LEADERSHIP / SERVICES
American Society for Clinical Oncology
-
Session Chair, Annual Meeting, 2003, 2009, 2010, 2015, 2016, 2018
-
Annual Meeting New Drug Symposium. 2017-2020, Chair, 2017-2019
-
Cancer Education Committee, 2013-2016, 2018 Biomarkers/Imaging Task Force, 2005-2006 Cancer Research Committee, 2006-2009
-
Chair, FDA Critical Path Subcommittee
-
Chair, ASCO-FDA Alternative Design Working Group ASCO Taxonomy Task Force, July-December, 2016
-
ASCO Taxonomy Committee, Founding member. Jan, 2017-Mar, 2020
-
TAPUR study tumor board, section Chair. June, 2016-March, 2020
-
JCO Precision Oncology Founding Associate Editor, 2016-2020
Cancer And Leukemia Group B/Alliance
-
Vice-Chair, Pharmacology and Experimental Therapeutics (PET) Committee March, 2001- September, 2011
-
Vice-Chair, Population Pharmacology and Pharmacogenomics (PPP) Committee September, 2011-2020
Coriell Personalized Medicine Collaborative.
-
Pharmacogenetics Advisory Committee March, 2010-2018.
Food and Drug Administration
-
Member, Sub-committee on Clinical Pharmacology September, 2002-July, 2007 Member, Committee on Clinical Pharmacology August, 2007-June, 2013.
-
Consultant & ad hoc reviewer, Gastrointestinal Advisory Committee. Aprepitant approval. March, 2003
-
Consultant & presenting expert, Pediatric Hematology/Oncology subcommittee, Oncology Drugs Advisory Committee July, 2003
-
Consultant, Third Wave Technologies Invader assay for UGT1A1, October, 2004.
-
Consultant, carbamazepine-induced cutaneous adverse effects. July, 2007.
National Institutes of Health
NIGMS Pharmacogenetics Research Network
-
Member, Executive Committee August, 2001-July, 2010
National Cancer Institute
-
Cancer Therapeutics Branch Site Visit Team, October, 2004,
-
Translational Research Working Group. October, 2005-2007
-
Medical Oncology Branch Site Visit Team, November, 2009.
-
NCI Colon/Rectal Clinical Trials Planning group, January, 2011
-
Developmental Therapeutics Study Section, 6/2005, 6/2006, 10/2006, 2/2007, 5/2007, June, 2008-June, 2010
-
NCI Frontiers of Predictive Oncology and Computing, July, 2016
-
Urologic Oncology Branch/Genitourinary Malignancies Branch Site visit Team , February, 2018
National Human Genome Research Institute
-
Member and Chair, Expert Scientific Panel, eMERGE Network (Electronic Medical Record and Genomics). February, 2008-December, 2019.
-
National Advisory Council for Human Genome Research, September, 2010-September, 2014
-
NHGRI Genomic Medicine Working Group, December, 2011-December, 2019
-
Organizer: Genome Medicine VIII meeting
-
Speaker: Genome Medicine II-IX meetings
Personalized Medicine Coalition
-
Board of Director, January, 2015-January, 2021
-
Chairman (with Dr Lincoln Nadauld), Science Policy Committee, January, 2019-present
Leadership
GRADUATE STUDENT TRAINING
Masters of Science
-
MSc Clinical Pharmacology
-
Kevin Dewar - 1996 University of Aberdeen - completed
-
Lloyd Matowe - 1997 University of Aberdeen - completed
-
-
MSc Human Genetics
-
Philip Carrott - 1998 University of Aberdeen - completed
-
Chrysteleu Lennou - 1998 University of Aberdeen - completed
-
Doctor of Philosophy (PhD)
-
Leslie Milne - 1994-1998 University of Glasgow - completed
-
Wiboon Wattanatorn - 1994-1998 Robert Gordan University - completed
-
Stephen Johnston - 1995-1999 University of Aberdeen - completed
-
Sharon Marsh - 1996-1999 University of Aberdeen - completed
-
Patrick Rooney - 1996-1999 University of Aberdeen - completed
-
Margaret-Mary Ameyaw - 1997-2000 University of Aberdeen- completed
-
Mohammed Tayeb - 1998-2002 University of Aberdeen- completed
Washington University School of Medicine Division of Biology and Biomedical Sciences MA/MD program
-
Steering committee 2001-2006
-
Chairman, Thesis committee:
-
Eunice Lee 2001-2002
-
Margo Funk, 2003-2004
-
-
Thesis committee membership:
-
Dan Tu 2002-2003,
-
Isaiah Turnbull 2002-2003
-
-
Doctor of Philosophy (PhD)
-
PhD Thesis committee service:
-
Eric Snyder 2001-2004
-
Yue Yu 2002-2004
-
Corey Pelletier 2003- 2006
-
Taylor Maxwell 2003-2006
-
Sharon Young 2003-2006
-
-
PhD Thesis Advisor:
-
Patrick Cahan 2005-2009
-
Janna Hutz 2005-2010
-
-
University of North Carolina
-
Doctor of Philosophy (PhD)
-
PhD Thesis Advisor:
-
Roshawn Watson 2006-2010 (Royster Fellowship Awardee)
-
Venita Grisham 2006-2010 (NIH F31 Awardee)
-
Dan Hertz 6/2008-1/2013 (AFPE Awardee)
-
Nancy Gillis 6/2012- 5/2017 (AFPE Awardee)
-
-
PhD Thesis committee service:
-
Patrick Roberts, 2006-2007
-
Huali Wu, 2006-2011 (committee Chair)
-
Christina Santos 2007-2011 (committee Chair)
-
Katie Theken, 2007-2011 (AFPE Awardee)
-
Jasmine Talemeh, 2008-2012 (AFPE awardee, committee Chair)
-
Gina Song 6/2008-5/2014, (committee chair)
-
Crissy Dodson (School of Nursing), 1/2010-12/2012
-
Katie Hacker (1/2011- 10/2013)
-
Kim Maxfield (1/2011-6/2015)
-
-
Masters of Science (MSc)
-
MSc Thesis Advisor: Brent Hehl 2010-2012
-
-
Central South University – Thesis Advisor
-
Masters of Science
-
Biaobo Xu (2016)
-
Weili Wang (2017)
-
Shangchen Xie (2018)
-
Ping Liao (2019)
-
Wei Li (2020)
-
-
Doctor of Philosophy (PhD)
-
Chengfang Zhou (2017)
-
Dongya Shen (expected 2019)
-
Precision Oncology Clinical Fellowship
-
Todd Knepper, PharmD (2016)
-
Cory Vela, PharmD (2016)
-
James Saller, MD (2016)
-
Daryoush Saeed-Vafa, MD (2017)
-
Ryan Nelson, PharmD (2020)
-
Bendiya Patel, MD (2020)
-
Michael Fusco, PharmD (2021)
Graduate Student Training
AWARD / RANKINGS
-
Alumni Professional Excellence Award. University of Washington School of Pharmacy, 1988.
-
American College of Clinical Pharmacy Young Investigator Award. April, 2000.
-
Fellow, American College of Clinical Pharmacy. October, 2004.
-
1st John Rodman Endowed Lectureship, St Jude Children’s Research Hospital. Individualized Therapy: In Our Lifetime? January 10, 2008.
-
2008 ASCPT - FDA Abrams Award and Lecture, FDA White Oak, MD, April, 2008.
-
2008 ACCP Therapeutic Frontiers Award, Louisville, KY, October, 2008
-
UNC Eshelman School of Pharmacy Academic Excellence Award in Research, 2007-2008
-
UNC Eshelman School of Pharmacy Academic Excellence Award in Mentoring, 2007-2008.
-
Guest Professor, Central South University, Changsha, China, October, 2009 – October 2014.
-
Guest Professor, Shanghai Sixth People’s Hospital, April, 2011.
-
Coriell Scientific Award, Coriell Institute for Medical Research, May, 2012
-
Foreign 1000 Talents Award, Central South University, People’s Republic of China, January, 2012
-
The 17th Annual Roy H. Behnke Distinguished Lectureship, University of South Florida 23rd Annual Health Research Day, Tampa, FL. February, 2013.
-
Tenth Annual Charles M. Gruber Lecture, Jefferson Medical College, May, 2014
-
Moffitt Cancer Center 2014 Population Science Top Publication Award, February, 2015
-
American College of Clinical Pharmacy Russell R. Miller Award, October, 2015
-
Fellow, American Society of Clinical Oncology, July, 2020
-
Expertise in Pharmacogenetics #1 USA, #2 World, 2020, 2021, https://www.expertscape.com/ex/pharmacogenetics
Awards
CONSULTING
Corporate Advising
-
Dr McLeod has served on the board of directors of both privately held and publically traded companies. He is currently an independent Director for the multinational Vyant Bio (Nasdaq: VYNT), as well as several privately held companies. Dr McLeod has also served in both member and chair roles for Scientific Advisory Committees and Medical Affairs Committees of such companies.
Pharma/Biotech
-
Dr McLeod is a frequently requested consultant by pharmaceutical and biotechnology companies in the areas of anticancer drug development, precision medicine (devices and drugs), and clinical pharmacology
Genomic Medicine
-
Dr McLeod is an active consultant in discovery, validation, and implementation of Genomic Medicine strategies for biomedical companies and health systems.
Start ups
-
Dr McLeod has founded a number of both non-profit and for profit new companies and provides consultative advise to such companies to help expedite their growth.
Academic scientific advisory board
-
Dr McLeod has served as a scientific advisor for a number of large academic initiatives. This has included service to the funding body or advising the scientific team. This has included federal initiatives, university/research institute internal efforts, or multiinstitution/multinational networks.
Consulting
Personal
PERSONAL
Family - Howard has been married to Donya McLeod since 1989. They have a daughter Katie and son Max
Ancient Cartography - Howard is a collector of 1500-1700 century maps, including a renown collection of historical maps of Jamaica
Rock Music - bass guitar, vocals The Potentials - 1982-1984. Wrote lyrics/music for 5 song EP, band featured future Rock and Roll Hall of Fame inductee Dave Krusen (Pearl Jam, Candlebox) on drums
CONTACT
EMAIL hmcleod1965@gmail.com
Wikipedia page: https://en.wikipedia.org/wiki/Howard_McLeod
SENT A NOTE
Contact
bottom of page